Recent patents on oral combination drug delivery and formulations

Recent Patents on Drug Delivery and Formulation

Volumn 5, Issue 1, 2011, Pages 52-60

  Hiremath, Praveen S ^a   Bhonsle, Shrikant A ^a   Thumma, Sridhar ^a   Vemulapalli, Viswatej ^a  

^a Pharmaceutics International Inc   (United States)

Author keywords

Analgesics drugs; Anti bacterial drugs and anti viral drugs; Anti inflammatory drugs; Cardiovascularsystem drugs; Central nervous system drugs; Combination drug delivery; Combination formulations

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ACETYLSALICYLIC ACID; AMLODIPINE; AMLODIPINE BESYLATE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTICONVULSIVE AGENT; ATORVASTATIN; CELECOXIB; DEXAMETHASONE; ESOMEPRAZOLE PLUS NAPROXEN; EZETIMIBE PLUS SIMVASTATIN; FAMOTIDINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; ISONIAZID PLUS RIFAMPICIN; MELAGATRAN; MEVINOLIN; NARCOTIC ANALGESIC AGENT; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; OPIATE ANTAGONIST; OXYCODONE; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; QUETIAPINE; REBOXETINE; ROFECOXIB; UNINDEXED DRUG; ZOLMITRIPTAN; ZONISAMIDE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; COMBINATION CHEMOTHERAPY; CONSTIPATION; CORONARY ARTERY DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG GRANULE; DRUG POTENTIATION; DRUG RELEASE; DUODENUM ULCER; DYSPEPSIA; ENDOTOXEMIA; FLUSHING; FOCAL EPILEPSY; GASTRITIS; HUMAN; HYPERLIPIDEMIA; LIVER INJURY; MIGRAINE; MONOTHERAPY; NONHUMAN; PAIN; PATENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SIDE EFFECT; STOMACH ULCER; SUSTAINED RELEASE FORMULATION; TABLET MATRIX; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; DRUG COMBINATION; DRUG INDUSTRY; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; ANALGESICS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIPYRETICS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG INDUSTRY; HUMANS; PATENTS AS TOPIC;

EID: 79954439729     PISSN: 18722113     EISSN: 18722113     Source Type: Journal    
DOI: 10.2174/187221111794109475     Document Type: Article

References (50)

1. Munos B. Lessons from 60 years of pharmaceutical innovation. NatRev Drug Discov 2009; 8: 959-68.
2. Parakh SR, Gothoskar AV, Karad MT. A novel method for the study of water absorption rates by swellable matrices. Pharm Tech 2003; 40-48.
3. Shmulewitz A, Langer R, Patton J. Convergence in biomedical technology. Nat Biotech 2006; 24: 277-280.
4. Mayer LD, Janoff AS. Optimizing combination chemotherapy by controlling drug ratios. Mol Interventions 2007; 7: 216-223.
5. WHO Model List of Essential Medicines. 16th List; March 2009(http://www.who.int/medicines/publications/essentialmedicines/en/index.html)
6. Hughes B. Tapping into combination pills for HIV. Nat Rev DrugDiscov 2009; 8: 439-40.
7. Burch, R.M., Goldenheim, P.D., Sackler, R.S. Synergistic analgesiccombination of opioid analgesic and cyclooxygenase-2 inhibitor.US20070191412 (2007).
8. Kaiko, R.F., Colucci, R.D. Opioid agonist/opioid antagonist/acetaminophen combinations. US6375957 (2002).
9. Plachetka, J., Gilbert, D. Dosage forms for administeringcombinations of drugs. US2007103113 (2008).
10. Raffa, R.B. Composition comprising a Tramadol material and anon-steroidal anti-inflammatory drug. US5516803 (1996).
11. Zhang, S., Wang, J. Sustained release formulations containingacetaminophen and Tramadol. US7374781 (2004).
12. Houghton, A., Cottney, J. Synergistic combination of an opioidanalgesic and a NSAID. US7375106 (2005).
13. Tidmarsh, G., Golombik, B.L., Lii T. Unit dose form withIbuprofen-Famotidine admixture. US20070043096 (2007).
14. Xu, J., Tidmarsh, G. Stable compositions of famotidine andibuprofen. US20090142393 (2009).
15. Tananbaum, J.B., Vadas, E., Goldsmith, M.A. Oral pharmaceuticalformulations containing non-steroidal anti-inflammatory drugs andacid inhibitors. US20100227854 (2010).
16. Plachetka, J.R. Pharmaceutical compositions for the coordinateddelivery of NSAIDs. US6926907 (2003).
17. Mainde, C., Vahile, P.R. Pharmaceutical compositions comprisingnon-steroidal antiinflammatory drug, antipyretic-analgesic drug andproton pump inhibitor. US20090220591 (2009).
18. Burch, R.M., Goldenheim, P.D., Sackler, R.S. Synergistic analgesiccombination of oxycodone and Rofecoxib. US6552031 (2003).
19. Codd, E.E., Martinez, R.P., Rogers, K.E. Composition comprisinga Tramadol material and an anticonvulsant drug. US6562856 (2003).
20. Oshlack, B., Wright, C., Haddox, D.J. Tamper-resistant oral opioidagonist formulations. US20080306104 (2004).
21. Guimberteau, F., Meyrueix, R., Soula, G. Anti-misusemicroparticulate oral drug form. US20100266701 (2010).
22. M. Combination product comprising melagatran and dexamethasone.US7449446 (2005).
23. Fink, M.P. Compositions including leukotriene antagonists andNSAIDs and methods of using the same. US20100221334 (2010).
24. Plachetka, J.R. Pharmaceutical compositions for the coordinateddelivery of naproxen and esomeprazole. US20100172983 (2010).
25. Ullah, I., Jain, N.B., Pharmaceutical composition containing acombination of a statin and aspirin and method. US6235311 (2001).
26. Myers, M., Sanghvi, P.P. Controlled release compositions andmethods for the treatment of hyperlipidemia. US6090830 (2000).
27. Moore, W.D., Fitzpatrick S., Seiler, C., Saklatvala, R., Petts, C.R.Pharmaceutical formulation. US7229982 (2004).
28. Mason, P.R. Synergistic effects of amlodipine and atorvastatinmetabolite as a basis for combination therapy. US7129265 (2002).
29. Papa, J., Henis, M.M.J. Synergistic combination therapy usingbenazepril and amlodipine for the treatment of cardiovasculardisorders and compositions therefor. US6162802 (2000).
30. Fossa, A.A. Synergistic therapeutic compositions and methods.US6900234 (2005).
31. Kim, S.W., Jun, S.S., Jo, Y.G., Koo, J.S., Kim, J.W., Son, J.W. Controlled release pharmaceutical composition containing thiazidesand angiotensin-II-receptor blockers. US20100143470 (2010).
32. Storm, K.H., Conley, C.P., Roush, J.A. Method of treating abacterial infection. US7250176 (2007).
33. Storm, K.H., Conley, C.P., Roush, J.A. Second release phaseformulation. US7011849 (2002).
34. Storm, K.H., Conley, C.P., Roush, J.A. Composition comprisingamoxicillin and potassium clavulanate. US6783773 (2004).
35. Storm, K.H., Conley, C.P., Roush, J.A. Amoxicillin and potassiumclavulanate dosage form. US6756057 (2003).
36. Barry, D.W., Clair, M.H.S. Synergistic combinations ofzidovudine, 1592U89 and 3TC. US6417191 (2002).
37. Voorspoels, J.F., Jans, E.M.J. Combination formulations.US20100190809 (2010).
38. Ikeda, F., Otomo, K., Wakai, Y., Matsumoto, S. Therapeuticcombination of a pneumocandin derivative and an antifungal agent. US7375081 (2005).
39. Arora, S.K., Sinha, N., Sinha, R., Upadhyaya R.S. Antimycobacterialpharmaceutical composition. US7491721 (2005).
40. Singh, A., Jain, R. Pharmaceutical compositions of anti-tuberculardrugs and process for their preparation. US7195769 (2003).
41. Sapte, V.R. Stabilized short-course chemotherapy (SCC) antituberculosisdrug compositions. US20050249804 (2005).
42. Gadde, K.M., Krishnan, R.K. Compositions of an anticonvulsantand an antipsychotic drug and methods of using the same foraffecting weight loss. US20090018115 (2009).
43. Taylor, D.P. Drug combinations. US6500827 (2002).
44. Lee, D. Combination of Quetiapine and Zolmitriptan. US20050020571 (2005).
45. Polvino, W.J. Enhanced migraine treatments based on ghrelinmimetics. US20100222328 (2010).
46. Virkki, M., Vahervuo, K., Ritala, M., Partanen, M., Niskanen, M., Linyulaakso, J., Laaksonen, M., Kervinen, L., Kallioinen, S.Pharmaceutical composition comprising entacapone, levodopa, andCarbidopa. US6500867 (2002).
47. Prudential Equity Group. Symbyax, First Medication for BipolarDepression Approved by FDA. Available at:http://www.healthyplace.com/Communities/Bipolar/Site/story_symbyax.htm
48. Spruill WM, Cunningham LM. Strategies for extending the life ofpatents. BioPharm Int 2005.
49. Hughes B. Tapping into combination pills for HIV. Nat Rev DrugDiscov 2009; 8: 439-40.
50. Patent Act 35 USC §103 (2006).